Home LiteratureArticle Details
PMID: 15634214 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Golgi vesiculation induced by cholesterol occurs by a dynamin- and cPLA2-dependent mechanism.

Traffic (Copenhagen, Denmark) ·Vol. 6 ·No. 2 ·2005-02-00 ·Pages 144-56

Grimmer S, Ying M, Wälchli S, van Deurs B, Sandvig K

Abstract

It was recently demonstrated that an increase in the cellular cholesterol level leads to vesiculation of the Golgi apparatus. This vesiculation affects the entire Golgi apparatus and is a reversible process. We have now started to elucidate the mechanism behind this cholesterol-induced vesiculation of the Golgi apparatus. Transient transfection of cells with dominant negative mutant constructs of dynamin 1 and 2 inhibited the vesiculation; expression of dynK44A in HeLa cells stably transfected with this construct had the same effect. However, the vesiculation seems to be independent of clathrin, as cholesterol-induced vesiculation still occurred following knock down of clathrin heavy chain in HeLa cells using RNA interference as well as in BHK cells where expression of antisense to clathrin heavy chain had been induced. Importantly, the cPLA2 inhibitor MAFP and the chelator BAPTA-AM that binds cytosolic Ca2+ inhibited the cholesterol-induced vesiculation, suggesting involvement of a cPLA2 that requires cytosolic Ca2+ for translocation to membranes. Furthermore, in response to an increased cellular cholesterol level, an EGFP-cPLA2 fusion protein translocated to the Golgi apparatus. Thus, our results demonstrate that the cholesterol-induced vesiculation of the Golgi apparatus is mediated by a cPLA2- and dynamin-dependent mechanism.

MeSH Terms
Animals Antibodies, Monoclonal/metabolism Arachidonic Acids/pharmacology Chelating Agents/pharmacology Cholesterol/metabolism,pharmacology Dynamins/genetics,metabolism Egtazic Acid/analogs & derivatives,pharmacology Enzyme Inhibitors/pharmacology Fluorescent Antibody Technique, Indirect Golgi Apparatus/drug effects,metabolism Green Fluorescent Proteins/metabolism Group IV Phospholipases A2 HeLa Cells Humans Isoenzymes/metabolism Mice Mutation Organophosphonates/pharmacology Phospholipases A/antagonists & inhibitors,metabolism RNA, Small Interfering/metabolism Recombinant Fusion Proteins/metabolism Transfection beta-Cyclodextrins/metabolism
Chemicals
Antibodies, Monoclonal Arachidonic Acids Chelating Agents Enzyme Inhibitors Isoenzymes Organophosphonates RNA, Small Interfering Recombinant Fusion Proteins beta-Cyclodextrins methyl arachidonylfluorophosphonate 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester Green Fluorescent Proteins Egtazic Acid Cholesterol Phospholipases A Group IV Phospholipases A2 Dynamins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Grimmer Stine
Institute for Cancer Research, Department of Biochemistry, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway.
Ying Ming
Wälchli Sébastien
van Deurs Bo
Sandvig Kirsten
Article Info
Journal
Traffic (Copenhagen, Denmark)
Abbr.
Traffic
ISSN
1398-9219
Published
2005-02-00
Pages
144-56
Language
English
Region
England
NLM ID
100939340
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com